Has Erica Liu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,064 in general payments to Erica Liu, MD across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erica Liu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erica Liu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erica Liu, MD

Ophthalmology · Torrance, CANPI 1528402633

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec, Inc. accounts for 63.2% of it on its own, with 15 other manufacturers making up the rest. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,064in general payments, 2019–2025

Across 113 payments — averaging $248.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Carl Zeiss Meditec, Inc.$18K
Carl Zeiss Meditec USA, Inc.$8K
Alcon$717
Johnson & Johnson Surgical Vision, Inc.$292
Bausch & Lomb Americas Inc.$204
AbbVie$191
plus $874 from 10 others

$9,356in research payments, 2019–2025

Across 3 payments — averaging $3118.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Carl Zeiss Meditec, Inc.$9K

What the payments were for

Consulting fees$7,94028%
Speaking & faculty fees$15,03054%
Travel & lodging$9123%
Food & beverage$4,09015%
Education$50%
Gifts$860%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Carl Zeiss Meditec, Inc.	25	$17,723
Carl Zeiss Meditec USA, Inc.	30	$8,061
Alcon	16	$717
Johnson & Johnson Surgical Vision, Inc.	8	$292
Bausch & Lomb Americas Inc.	2	$204
AbbVie	2	$191
Tarsus Pharmaceuticals, Inc.	5	$176
Shire North American Group Inc	9	$172
Harrow Eye, LLC	3	$147
Janssen Scientific Affairs, LLC	1	$114
Rxsight Inc	4	$86
Biotissue Holdings Inc.	2	$49
Sight Sciences, Inc.	1	$38
Beaver-visitec International, Inc.	2	$36
Sun Pharmaceutical Industries Inc.	2	$36
Glaukos Corporation	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,064 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Medicare billing

Part B allowed, 2024

$71,040

Medicare patients

227

Services billed

733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	25	$786
Latanoprost	34	$291
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	13	$227
Timolol Maleate	19	$212
ErythromycinErythromycin Base	18	$147

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Torrance

Amr KouchoukTorrance$323K
Daniel SchwartzSan Francisco$8M
Michael BerlinWest Hollywood$5.7M
Gilbert KlimanMenlo Park$1.5M
Kuldev SinghStanford$1.5M
Raymond DouglasBeverly Hills$1.3M
John AffeldtLoma Linda$1.1M
Srinivas SaddaPasadena$1M
Sheri RowenNewport Beach$1M
Savak TeymoorianLaguna Hills$955K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →